|Day Low/High||36.67 / 37.68|
|52 Wk Low/High||5.82 / 39.02|
Jim Cramer is bullish on Halliburton, Schlumberger, Cypress Semiconductor and Celgene
Tech's organic growth and visibility has been apparent all year, says Jim Cramer.
Jefferies analyst Laurence Alexander upgraded Chemours' stock, suggesting industry risks continue to be discounted.
Here are Wednesday's top research calls, including a downgrade of Twitter and new coverage of Facebook, Amazon and Alphabet.
CC has made a strong upside move but more gains are anticipated in the weeks ahead.
The good vibes that carried Wall Street to new records last week lingered on into Monday's session.
The Dow Jones Industrial Average led Wall Street's gains on Monday on leftover goodwill from last week's Trump-inspired rally.
The New Facility Will Triple the Company's Capacity of Its Low Global Warming Potential, HFO-1234yf-Based Refrigerant Products
Jim Cramer is bullish on Box and Six Flags; bearish on Chemours and Zoe's Kitchen.
Jim Cramer says: Evaluate the individual companies in the Dow based on fundamentals, not some 'Trumpian alchemy.'
Cramer is taking Magellan Midstream Partners over EQT Midstream and is waiting for Ionis Pharmaceuticals to go lower.
Buccini/Pollin Group to Purchase the Building, Renovate, and Lease Office Space Back to Chemours
Going into earnings what the market needs now is more negativity, Cramer says.
Jim Cramer says he's still 'a believer' in KKR and Opko.
Stocks kept rallying right through and after this rate hike, says Jim Cramer.
Jim Cramer urges caution with phamaceutical companies Supernus and Ariad
Jim Cramer explains the rotation, looks ahead to next week.
These stocks have short-term gain catalysts and longer-term growth potential.